I
CPRX

InceptionR’s Catalyst Pharmaceutical CPRX Stock Holding History

InceptionR’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Buy
+8,562
New +$204K 0.05% 571
2025
Q1 		– Sell
-17,329
Closed -$362K – 596
2024
Q4 		$362K Sell
17,329
-2,279
-12% -$49K 0.08% 402
2024
Q3 		$390K Buy
+19,608
New +$363K 0.1% 388

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

InceptionR's CPRX Position: Q1 2026 in Review

InceptionR opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 8,562 shares worth $212K. The stake represents 0.05% of the portfolio and ranks #571 among its holdings. This is a return to the name: InceptionR previously reported a position in CPRX as recently as Q4 2024.

InceptionR first reported a position in CPRX in Q3 2024 and has held it in 3 quarters since. The position peaked at $390K in Q3 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • InceptionR held 8,562 shares of Catalyst Pharmaceutical worth $212K as of Q1 2026.
  • Catalyst Pharmaceutical was a new InceptionR position in Q1 2026.
  • Catalyst Pharmaceutical made up 0.05% of InceptionR's portfolio in Q1 2026, its #571 holding.
  • InceptionR first reported a position in Catalyst Pharmaceutical in Q3 2024 and has held it in 3 quarters since.
  • InceptionR's Catalyst Pharmaceutical position peaked at $390K in Q3 2024.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.